Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy
- PMID: 17359355
- DOI: 10.1111/j.1365-2990.2007.00830.x
Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy
Abstract
Spinal and bulbar muscular atrophy (SBMA) or Kennedy's disease is a motor neurone disease characterized by muscle atrophy, weakness, contraction fasciculations and bulbar involvement. SBMA mainly affects males, while females are usually asymptomatic. SBMA is caused by expansion of a polyglutamine (polyQ)-encoding CAG trinucleotide repeat in the androgen receptor (AR) gene. AR belongs to the heat shock protein 90 (Hsp90) client protein family. The histopathologic hallmarks of SBMA are diffuse nuclear accumulation and nuclear inclusions of the mutant AR with expanded polyQ in residual motor neurones in the brainstem and spinal cord as well as in some other visceral organs. There is increasing evidence that the ligand of AR and molecular chaperones play a crucial role in the pathogenesis of SBMA. The success of androgen deprivation therapy in SBMA mouse models has been translated into clinical trials. In addition, elucidation of its pathophysiology using animal models has led to the development of disease-modifying drugs, that is, Hsp90 inhibitor and Hsp inducer, which inhibit the pathogenic process of neuronal degeneration. SBMA is a slowly progressive disease by nature. The degree of nuclear accumulation of mutant AR in scrotal skin epithelial cells was correlated with that in spinal motor neurones in autopsy specimens; therefore, the results of scrotal skin biopsy may be used to assess the efficacy of therapeutic trials. Clinical and pathological parameters that reflect the pathogenic process of SBMA should be extensively investigated.
Similar articles
-
Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).Exp Neurol. 2006 Jul;200(1):8-18. doi: 10.1016/j.expneurol.2006.01.021. Epub 2006 Mar 2. Exp Neurol. 2006. PMID: 16513111 Review.
-
Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG).Ann N Y Acad Sci. 2006 Nov;1086:21-34. doi: 10.1196/annals.1377.012. Ann N Y Acad Sci. 2006. PMID: 17185503 Review.
-
Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker.Ann Neurol. 2006 Mar;59(3):520-6. doi: 10.1002/ana.20735. Ann Neurol. 2006. PMID: 16358333 Clinical Trial.
-
Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA).Neuropathology. 2009 Aug;29(4):509-16. doi: 10.1111/j.1440-1789.2009.01013.x. Epub 2009 May 22. Neuropathology. 2009. PMID: 19486304 Review.
-
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.Nat Med. 2005 Oct;11(10):1088-95. doi: 10.1038/nm1298. Epub 2005 Sep 11. Nat Med. 2005. PMID: 16155577
Cited by
-
p62/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse model.J Neurosci. 2013 May 1;33(18):7710-27. doi: 10.1523/JNEUROSCI.3021-12.2013. J Neurosci. 2013. PMID: 23637164 Free PMC article.
-
Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy.Hum Mol Genet. 2015 Jan 1;24(1):64-75. doi: 10.1093/hmg/ddu419. Epub 2014 Aug 13. Hum Mol Genet. 2015. PMID: 25122660 Free PMC article.
-
Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.J Genet. 2010 Dec;89(4):497-526. doi: 10.1007/s12041-010-0072-4. J Genet. 2010. PMID: 21273704 Review.
-
The role of autophagy-lysosomal pathway in motor neuron diseases.Biochem Soc Trans. 2022 Oct 31;50(5):1489-1503. doi: 10.1042/BST20220778. Biochem Soc Trans. 2022. PMID: 36111809 Free PMC article. Review.
-
Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?BMC Neurosci. 2008 Dec 3;9 Suppl 2(Suppl 2):S7. doi: 10.1186/1471-2202-9-S2-S7. BMC Neurosci. 2008. PMID: 19090995 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials